NO20014936L - Anti-idiotypiske antistoffer mot antistoffer som inhiberer bindingen av immunglobulin til sin höyaffinitetsreseptor - Google Patents

Anti-idiotypiske antistoffer mot antistoffer som inhiberer bindingen av immunglobulin til sin höyaffinitetsreseptor

Info

Publication number
NO20014936L
NO20014936L NO20014936A NO20014936A NO20014936L NO 20014936 L NO20014936 L NO 20014936L NO 20014936 A NO20014936 A NO 20014936A NO 20014936 A NO20014936 A NO 20014936A NO 20014936 L NO20014936 L NO 20014936L
Authority
NO
Norway
Prior art keywords
antibodies
immunoglobulin
inhibit
binding
affinity receptor
Prior art date
Application number
NO20014936A
Other languages
English (en)
Norwegian (no)
Other versions
NO20014936D0 (no
Inventor
Franz Kricek
Beda Stadler
Monique Vogel
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of NO20014936D0 publication Critical patent/NO20014936D0/no
Publication of NO20014936L publication Critical patent/NO20014936L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/42—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/42—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins
    • C07K16/4208—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig
    • C07K16/4241—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig against anti-human or anti-animal Ig
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/55—Fab or Fab'

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Otolaryngology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO20014936A 1999-04-14 2001-10-10 Anti-idiotypiske antistoffer mot antistoffer som inhiberer bindingen av immunglobulin til sin höyaffinitetsreseptor NO20014936L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9908533.4A GB9908533D0 (en) 1999-04-14 1999-04-14 Organic compounds
PCT/EP2000/003288 WO2000063252A1 (fr) 1999-04-14 2000-04-12 Antibiotiques anti-idiotypiques contre des anticorps inhibant la fixation de l'immunoglobuline e a son recepteur a haute affinite

Publications (2)

Publication Number Publication Date
NO20014936D0 NO20014936D0 (no) 2001-10-10
NO20014936L true NO20014936L (no) 2001-12-03

Family

ID=10851525

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20014936A NO20014936L (no) 1999-04-14 2001-10-10 Anti-idiotypiske antistoffer mot antistoffer som inhiberer bindingen av immunglobulin til sin höyaffinitetsreseptor

Country Status (29)

Country Link
US (1) US7041288B2 (fr)
EP (1) EP1169353B1 (fr)
JP (1) JP4109829B2 (fr)
KR (1) KR100492202B1 (fr)
CN (1) CN1268644C (fr)
AR (1) AR029624A1 (fr)
AT (1) ATE392437T1 (fr)
AU (1) AU767712B2 (fr)
BR (1) BR0009781A (fr)
CA (1) CA2363991C (fr)
CO (1) CO5241329A1 (fr)
CZ (1) CZ20013673A3 (fr)
DE (1) DE60038608T2 (fr)
ES (1) ES2302693T3 (fr)
GB (1) GB9908533D0 (fr)
HK (1) HK1044544B (fr)
HU (1) HUP0200713A2 (fr)
IL (2) IL145507A0 (fr)
MX (1) MXPA01010348A (fr)
MY (1) MY141459A (fr)
NO (1) NO20014936L (fr)
PE (1) PE20010046A1 (fr)
PL (1) PL350676A1 (fr)
PT (1) PT1169353E (fr)
RU (1) RU2253655C2 (fr)
SK (1) SK14592001A3 (fr)
TR (1) TR200102877T2 (fr)
WO (1) WO2000063252A1 (fr)
ZA (1) ZA200107906B (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6913749B2 (en) 1998-11-02 2005-07-05 Resistentia Pharmaceuticals Ab Immunogenic polypeptides for inducing anti-self IgE responses
GB0103174D0 (en) * 2001-02-08 2001-03-28 Smithkline Beecham Plc Novel method of treatment
EP1239032A1 (fr) 2001-03-02 2002-09-11 Société des Produits Nestlé S.A. Bactéries lactiques en tant qu'agents pour le traitement et la prévention des allergies
SE0101093D0 (sv) * 2001-03-28 2001-03-28 Pharmacia Diagnostics Ab Novel compound for treatment of allergy and asthma
EP1497654A4 (fr) 2001-08-13 2006-06-07 Chen Swey Shen Alex Vaccins d'immunoglobuline e et leurs procedes d'utilisation
TWI323265B (en) 2002-08-06 2010-04-11 Glaxo Group Ltd Antibodies
GB0306309D0 (en) 2003-03-19 2003-04-23 Glaxo Group Ltd Method of treatment
US8029783B2 (en) * 2005-02-02 2011-10-04 Genentech, Inc. DR5 antibodies and articles of manufacture containing same
CN101062949B (zh) * 2006-04-26 2011-07-27 上海抗体药物国家工程研究中心有限公司 重组抗人IgE单克隆抗体及其制备方法和用途
US20080118524A1 (en) * 2006-10-20 2008-05-22 Stefan Persson Anti-IgE Vaccines
UA95329C2 (ru) * 2006-12-14 2011-07-25 Шеринг-Плау Лтд. Собачий тимусный стромальный лимфопоэтин и его применение
ES2670576T3 (es) * 2009-09-03 2018-05-31 Pfizer Vaccines Llc Vacuna de PCSK9
LT3023438T (lt) 2009-09-03 2020-05-11 Merck Sharp & Dohme Corp. Anti-gitr antikūnai
US10214593B2 (en) 2013-04-02 2019-02-26 Samsung Electronics Co., Ltd. Anti-idiotype antibody against anti-c-MET antibody
BR112021016791A2 (pt) * 2019-02-26 2021-11-16 Sorrento Therapeutics Inc Proteínas de ligação de antígenos que se ligam a bcma

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
ATE45285T1 (de) 1983-11-07 1989-08-15 Wistar Inst Durch antiidiotype antikoerper induzierte immune antwort zu tumoren und viren.
CA1341235C (fr) 1987-07-24 2001-05-22 Randy R. Robinson Assemblage modulaire de genes d'anticorps, anticorps prepares de cette facon, ainsi que leur usage
AU618317B2 (en) * 1987-12-31 1991-12-19 Tanox Biosystems, Inc. Unique antigenic epitopes on ige-bearing b lymphocytes
CA2074089C (fr) 1990-01-23 2001-04-10 Tse-Wen Chang Segments extracellulaires des peptides d'ancrage de l'immunoglobuline e humaine, et anticorps specifiques
IT1238286B (it) 1990-03-26 1993-07-12 Dispositivo sensore di livello del liquido per caldaie a vapore.
US5512283A (en) 1990-07-06 1996-04-30 Allergene, Inc. Methods for the selective suppression of an immune response to dust mite der Pi
AU681360B2 (en) 1992-09-30 1997-08-28 Scripps Research Institute, The Human neutralizing monoclonal antibodies to human immunodeficiency virus
HUP9901109A3 (en) * 1996-03-01 1999-11-29 Novartis Ag Peptide immunogens for vaccination against and treatment of allergy
JPH11174A (ja) * 1997-06-13 1999-01-06 Asahi Breweries Ltd 酵母を用いた抗体Ｆａｂ断片の製造法
US5994511A (en) 1997-07-02 1999-11-30 Genentech, Inc. Anti-IgE antibodies and methods of improving polypeptides
AU762711C (en) 1998-04-24 2004-05-27 Fang Fang Identifying peptide ligands of target proteins with target complementary library technology (TCLT)

Also Published As

Publication number Publication date
KR20020007366A (ko) 2002-01-26
CA2363991A1 (fr) 2000-10-26
CN1268644C (zh) 2006-08-09
CO5241329A1 (es) 2003-01-31
ZA200107906B (en) 2003-08-27
GB9908533D0 (en) 1999-06-09
WO2000063252A1 (fr) 2000-10-26
BR0009781A (pt) 2002-01-08
AU767712B2 (en) 2003-11-20
PL350676A1 (en) 2003-01-27
ATE392437T1 (de) 2008-05-15
JP2002544125A (ja) 2002-12-24
EP1169353A1 (fr) 2002-01-09
SK14592001A3 (sk) 2002-05-09
AU3966000A (en) 2000-11-02
KR100492202B1 (ko) 2005-06-03
TR200102877T2 (tr) 2002-01-21
JP4109829B2 (ja) 2008-07-02
CA2363991C (fr) 2010-06-08
IL145507A (en) 2008-11-03
IL145507A0 (en) 2002-06-30
AR029624A1 (es) 2003-07-10
PT1169353E (pt) 2008-07-14
EP1169353B1 (fr) 2008-04-16
RU2253655C2 (ru) 2005-06-10
HK1044544A1 (en) 2002-10-25
NO20014936D0 (no) 2001-10-10
DE60038608D1 (de) 2008-05-29
US20020141989A1 (en) 2002-10-03
ES2302693T3 (es) 2008-08-01
HUP0200713A2 (en) 2002-07-29
MXPA01010348A (es) 2002-10-23
US7041288B2 (en) 2006-05-09
PE20010046A1 (es) 2001-02-23
CN1346372A (zh) 2002-04-24
MY141459A (en) 2010-04-30
CZ20013673A3 (cs) 2002-05-15
HK1044544B (zh) 2008-11-21
DE60038608T2 (de) 2009-06-10

Similar Documents

Publication Publication Date Title
NO20014936L (no) Anti-idiotypiske antistoffer mot antistoffer som inhiberer bindingen av immunglobulin til sin höyaffinitetsreseptor
NO975705L (no) Peptider og forbindelser som binder til trombopoietinreseptor
DK0906784T3 (da) Fremgangsmåde til fremstilling af bundne zeolitter
EP1572874A3 (fr) Anticorps se liant de maniere immunospecifique a des recepteurs de trail
EP1465925A4 (fr) Anticorps se liant de maniere immunospecifique a des recepteurs trail
NO20033074L (no) Antistoffer mot reseptoren for insulin-lignende vekstfaktor I
CY2007012I2 (el) Αντισωματα anti-vegf
NO991162D0 (no) Monoklonale antistoffer mot det ekstracellulµre domene av humant VEGF-reseptorprotein (KDR)
NO302964B1 (no) Bygningselementmodul, særlig beregnet for legging av gulv
DK1572874T3 (da) Antistoffer, der immunospecifikt binder til TRAIL receptorer
DK1201655T3 (da) Fremgangsmåde til fremstilling af non-steroide glucocorticoidreceptormodulatorer
NO20015227D0 (no) Fremgangsmåte for å öke effektiviteten til anti-cancer midler
NO930163D0 (no) Inhibering av mac-1-reseptorbinding til fibrinogen ved anvendelse av d30-homologer
DE69828154D1 (de) Anti-alphavbeta3 humanizierte monoklonale antikörper
NO20000797L (no) Innretning for amorf binding av rørelementer
AU1190101A (en) Engineering antibodies that bind irreversibly
DE69811110D1 (de) Phenyl-alkyl imidazole als h3 rezeptor antagonisten
NO994524D0 (no) Modulatorer av funksjonen til reseptorene til TNF/NGF-reseptorfamilien
DK0973769T3 (da) Fremgangsmåde til fremstilling af eprosartan
NO20040233L (no) Binding av kornmaterialer til polyolefinoverflater
NO20015376L (no) Peptider fra TT-virus-sekvensen og monospesifikke antistoffer som binder til TT-viruset
AU2002352676A1 (en) Antibodies that immunospecifically bind to trail receptors
AU2001297702A1 (en) Antibodies that immunospecifically bind to trail receptors
FR2770239B1 (fr) Element de construction pour plancher prefabrique
NO980671L (no) Fremgangsmåte for omdanning av lavere alkaner til höyere hydrokarboner

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application